Access to Care: Pharmaceutical Patents
Once a month, the Crohn's & Colitis Foundation (US) brings all staff together (from all the departments at the Foundation) to share information, resources, and updates.
Tag #Patientsandpatents
Crohn’s and Colitis Foundation of the USA on the Patients and patents campaign
In this episode of Arthritis Consumer Experts' Arthritis At Home, host Cheryl Koehn speaks with Laura Wingate, Chief Education, Support, and Advocacy Officer of the Crohn’s and Colitis Foundation of the USA, about the Patients and patents campaign.
Access to Care: Pharmaceutical Patents Webinar by Crohn’s & Colitis Foundation
This webinar will help you understand patents clearly as well as encourage patients and caregivers to promote more timely availability of generics and biosimilars.
Australian Patient Advocacy Alliance partners on launch of Patients and patents campaign
In this episode of Arthritis Consumer Experts' Arthritis At Home, host Cheryl Koehn speaks with Deidre Mackechnie, Executive Officer of the Australian Patient Advocacy Alliance, about her organization’s partnering with the Patients and patents campaign.
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
A recent article published on BioSpace summarizes an analysis conducted by Sean Tu of the University of Alabama School of Law. Tu's work cites multiple examples of pharmas using what the authors term serial litigation to stave off would-be competitors for years, allowing them to keep prices high.
“Canada’s drug access debate has two ends: patients are caught in the middle,” Op-Ed by Arthritis Consumer Experts (ACE)
ACE submitted an Op-Ed to the Globe and Mail, Canada’s national newspaper of record in response to an article focused on whether Canada’s drug pricing policies discourage pharmaceutical companies from launching innovative therapies.
Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products
This report from the International Generic and Biosimilar Medicines Association looks at the various strategies...
Patients and patents campaign partners launch website
Prescription drug prices continue to rise around the world, putting essential medications out of reach for too many people living with chronic diseases.
Interview: Patients and patents – Understanding how pharmaceutical patents affect medication cost
This Arthritis Consumer Experts Arthritis At Home explores why some medications are so expensive and the role pharmaceutical patents play in access to affordable treatment.
Beyond regulatory delays: How patent misuse impacts access to affordable medications
This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars and generics in Canada.